Multiple myeloma highlights from ASCO 2016: monoclonal antibodies and oral proteasome inhibitors
Current research on CD19 targeted CAR T-cells in relapsed B-cell ALL
Overview of the International Conference on Malignant Lymphoma (ICML) 2017
What is the best treatment in the next few years to achieve more treatment-free remission in CML?
Developments in CML over the past 30 years and where we are today